Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-05-03 Tallett Elizabeth E Director Grant or award · Stock Option (Right to Buy) +6,134 6,134
2023-05-03 SAGAN PAUL Director Grant or award · Stock Option (Right to Buy) +6,134 6,134
2023-05-03 Nader Francois Director Grant or award · Stock Option (Right to Buy) +6,134 6,134
2023-05-03 NABEL ELIZABETH G Director Grant or award · Stock Option (Right to Buy) +4,601 4,601
2023-05-03 NABEL ELIZABETH G Director Grant or award · Restricted Stock Units +732 732
2023-05-03 LANGER ROBERT Director Grant or award · Stock Option (Right to Buy) +6,134 6,134
2023-05-03 Horning Sandra Director Grant or award · Stock Option (Right to Buy) +6,134 6,134
2023-05-03 Berenson Stephen Director Grant or award · Stock Option (Right to Buy) +4,601 4,601
2023-05-03 Berenson Stephen Director Grant or award · Restricted Stock Units +732 732
2023-05-03 AFEYAN NOUBAR Director Grant or award · Stock Option (Right to Buy) +6,134 6,134
2023-05-03 Bancel Stephane Chief Executive Officer Exercise or conversion 10b5-1 +40,000 $0.99 $40K 5,451,946
2023-05-03 Bancel Stephane Chief Executive Officer Sale 10b5-1 −13,570 $130.60 $1.8M 5,438,376
2023-05-03 Bancel Stephane Chief Executive Officer Sale 10b5-1 −21,854 $131.54 $2.9M 5,416,522
2023-05-03 Bancel Stephane Chief Executive Officer Sale 10b5-1 −4,576 $132.12 $605K 5,411,946
2023-05-03 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −40,000 627,155
2023-04-28 NABEL ELIZABETH G Director Exercise or conversion +670 1,373
2023-04-28 NABEL ELIZABETH G Director Exercise or conversion · Restricted Stock Units −670 0
2023-04-28 Horning Sandra Director Exercise or conversion +670 1,373
2023-04-28 Horning Sandra Director Exercise or conversion · Restricted Stock Units −670 0
2023-04-28 Berenson Stephen Director Exercise or conversion +670 21,471

Page 48 of 66 · 1,314 trades